Peter E Schwartz MD
John Slade Ely Professor of Obstetrics, Gynecology, and Reproductive Sciences; Vice Chair, Gynecology; Section Chief, Gynecologic Oncology
Departments & Organizations
Yale Medical Group
Office of Student ResearchCancer Center, Yale: Gynecologic Oncology Program; Cancer Genetics & GenomicsObstetrics, Gynecology & Reproductive Sciences: Gynecologic Oncology; Ovarian Cancer Program, Early Detection; Discovery to CureCancer Genetics
Ovarian Cancer; Uterine; Vaginal; Cervical and vulvar cancer; Screening for ovarian cancer more...
- M.D., Albert Einstein College, 1966
- Schwartz PE. Contemporary considerations for neoadjuvant chemotherapy in primary ovarian cancer. Cur Oncol Rep2009; 11: (in press).
- Schwartz PE. Cytoreductive surgery in the management of ovarian cancer. Oncology 2008; 22: 1025-1033
- Hou JY, Kelly MG, Yu H,McAlpine JN, Azodi M, Rutherford TJ, Schwartz PE. Neoadjuvant chemotherapy lessens surgical morbidity in advanced ovarian cancer and leads to improved survival in Stage IV disease. Gynecol Oncol 2007; 105: 211-217